Policy & Regulation
20 November 2026 - Taiwan-based clinical-stage drug developer Caliway Biopharmaceuticals (TWSE: 6919) said on Friday it has received authorisation from the Center for Drug Evaluation of China's N...
20 November 2026 - Ophthalmic pharmaceutical company Tenpoint Therapeutics Ltd announced on Friday a New Drug Submission to Health Canada seeking approval of YUVEZZI (carbachol and brimonidine tartrat...
20 November 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Friday that the Phase 3 TroFuse-015 trial evaluating investigational dr...
20 November 2026 - Biotechnology company BioMimetix JV LLC announced on Thursday the publication of results from a multicentre Phase I/II clinical trial evaluating BMX-001, a redox-active metalloporph...
20 November 2026 - Kibow Biotech, a developer of probiotic dietary supplements for kidney health, announced on Thursday the availability of its flagship product, Renadyl, in Canada.Developed through d...
20 November 2026 - Interlude Biopharma Co, a late-stage, drug-development company focused on celiac disease, announced on Thursday the company's public launch at the 21st International Celiac Dis...